Point-of-care hemoglobin meters show high sensitivity but lower specificity versus analyzer in Ghanaian study
This cross-sectional study evaluated 100 participants who visited the laboratory for complete blood count at Aniniwaa Medical Centre in Kumasi, Ghana. Researchers compared hemoglobin measurements from two point-of-care devices (Urit and Mission) against a fully automated hematology analyzer as the reference standard.
The prevalence of anemia varied substantially across methods: 28% by the analyzer, 60% by the Urit meter, and 64% by the Mission meter. Both point-of-care devices demonstrated 100% sensitivity for detecting anemia but had low specificity (55.6% for Urit and 50.0% for Mission). Compared to the analyzer, both meters showed negative biases: Urit underestimated hemoglobin by 1.665 g/dL and Mission by 1.55 g/dL.
No safety or tolerability data were reported for the devices. Key limitations include the single-center design, lack of reported confidence intervals or p-values for the findings, and absence of information about funding or conflicts of interest. The study did not report primary or secondary outcomes explicitly.
For clinical practice, these findings suggest that while point-of-care hemoglobin meters offer convenience and portability for field screening, they systematically underestimate hemoglobin values and have concerningly low specificity. The automated hematology analyzer remains more accurate and reliable for definitive anemia diagnosis in clinical settings. Clinicians should interpret point-of-care hemoglobin results cautiously, particularly when values are near diagnostic thresholds.